正电子发射断层扫描在非小细胞肺癌管理中的作用。
The role of positron emission tomography in the management of non-small cell lung cancer.
作者信息
Behzadi Abdollah, Ung Yee, Lowe Val, Deschamps Claude
机构信息
Department of Surgery, The Scarborough Hospital, Toronto, Ont.
出版信息
Can J Surg. 2009 Jun;52(3):235-42.
Abstract
The potential use of positron emission tomography (PET) imaging in patients with non-small cell lung cancer (NSCLC) is broadly divided into 5 categories: management of solitary pulmonary nodule, mediastinal lymph node evaluation, detection of metastases, evaluation of response to chemoradiation and detection of recurrence. The purpose of this review is to discuss the current clinical applications of (18)F-fluorodeoxyglucose PET in patients with NSCLC and to discuss future applications and developments of this technology.
摘要
正电子发射断层扫描（PET）成像在非小细胞肺癌（NSCLC）患者中的潜在用途大致可分为5类：孤立性肺结节的管理、纵隔淋巴结评估、转移灶检测、放化疗反应评估以及复发检测。本综述的目的是讨论（18）F-氟脱氧葡萄糖PET在NSCLC患者中的当前临床应用，并探讨该技术的未来应用和发展。
相似文献
1
The role of positron emission tomography in the management of non-small cell lung cancer.
Can J Surg. 2009 Jun;52(3):235-42.
2
Combined contrast-enhanced computed tomography and 18-fluoro-2-deoxy-D-glucose-positron emission tomography in the diagnosis and staging of non-small cell lung cancer.
Semin Thorac Cardiovasc Surg. 2011 Spring;23(1):43-50. doi: 10.1053/j.semtcvs.2011.05.003.
3
Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysis.
Ann Intern Med. 2003 Dec 2;139(11):879-92. doi: 10.7326/0003-4819-139-11-200311180-00013.
4
Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography.
Eur J Cardiothorac Surg. 2009 Sep;36(3):440-5. doi: 10.1016/j.ejcts.2009.04.003. Epub 2009 May 22.
5
Diagnostic value of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography for the detection of metastases in non-small-cell lung cancer patients.
Int J Cancer. 2013 Jan 15;132(2):E37-47. doi: 10.1002/ijc.27779. Epub 2012 Sep 1.
6
Endoscopic ultrasound-guided fine needle aspiration of mediastinal lymph node in patients with suspected lung cancer after positron emission tomography and computed tomography scans.
Ann Thorac Surg. 2005 Jan;79(1):263-8. doi: 10.1016/j.athoracsur.2004.06.089.
7
Node/aorta and node/liver SUV ratios from (18)F-FDG PET/CT may improve the detection of occult mediastinal lymph node metastases in patients with non-small cell lung carcinoma.
Acad Radiol. 2012 Jun;19(6):685-92. doi: 10.1016/j.acra.2012.02.013. Epub 2012 Mar 28.
8
Diagnostic value of dual time-point 18 F-FDG PET/CT versus single time-point imaging for detection of mediastinal nodal metastasis in non-small cell lung cancer patients: a meta-analysis.
Acta Radiol. 2015 Jun;56(6):681-7. doi: 10.1177/0284185114535210. Epub 2014 Jun 10.
9
Combining independent studies of diagnostic fluorodeoxyglucose positron-emission tomography and computed tomography in mediastinal lymph node staging for non-small cell lung cancer.
Tumori. 2006 Jul-Aug;92(4):327-33. doi: 10.1177/030089160609200412.
10
Accuracy and predictive features of FDG-PET/CT and CT for diagnosis of lymph node metastasis of T1 non-small-cell lung cancer manifesting as a subsolid nodule.
Eur Radiol. 2012 Jul;22(7):1556-63. doi: 10.1007/s00330-012-2395-4. Epub 2012 Feb 24.
引用本文的文献
1
Is FDG-PET/CT Scan Useful in the Detection of Subcentimeter Mediastinal Lymph Node Involvement in Patients With Lung Carcinoma?
Cureus. 2024 Nov 27;16(11):e74572. doi: 10.7759/cureus.74572. eCollection 2024 Nov.
2
Thoracic positron emission tomography: F-fluorodeoxyglucose and beyond.
J Thorac Dis. 2020 Nov;12(11):6978-6991. doi: 10.21037/jtd-2019-cptn-09.
3
FAPI-74 PET/CT Using Either F-AlF or Cold-Kit Ga Labeling: Biodistribution, Radiation Dosimetry, and Tumor Delineation in Lung Cancer Patients.
J Nucl Med. 2021 Feb;62(2):201-207. doi: 10.2967/jnumed.120.245084. Epub 2020 Jun 26.
4
measurement of glucose uptake after radiation and cetuximab treatment in head and neck cancer cell lines using 18F-FDG, gamma spectrometry and PET/CT.
Oncol Lett. 2019 Nov;18(5):5155-5162. doi: 10.3892/ol.2019.10916. Epub 2019 Sep 24.
5
Diagnostic value of F-FDG-PET/CT in benign lung diseases.
Kardiochir Torakochirurgia Pol. 2018 Mar;15(1):1-4. doi: 10.5114/kitp.2018.74667. Epub 2018 Mar 28.
6
PET/CT imaging in lung cancer: indications and findings.
J Bras Pneumol. 2015 May-Jun;41(3):264-74. doi: 10.1590/S1806-37132015000004479.
7
Challenges in optimizing chemoradiation in locally advanced non small-cell lung cancers in India.
South Asian J Cancer. 2013 Oct;2(4):265-71. doi: 10.4103/2278-330X.119893.
8
Diagnostic imaging in the preoperative management of lung cancer.
Surg Today. 2014 Jul;44(7):1197-206. doi: 10.1007/s00595-013-0660-z. Epub 2013 Jul 10.
9
Combination of radiological and gray level co-occurrence matrix textural features used to distinguish solitary pulmonary nodules by computed tomography.
J Digit Imaging. 2013 Aug;26(4):797-802. doi: 10.1007/s10278-012-9547-6.
10
Clinical application of pharmacokinetic analysis as a biomarker of solitary pulmonary nodules: dynamic contrast-enhanced MR imaging.
Magn Reson Med. 2012 Nov;68(5):1614-22. doi: 10.1002/mrm.24150. Epub 2012 Jan 9.
本文引用的文献
1
PET for the evaluation of solitary pulmonary nodules.
J Nucl Med. 2009 Feb;50(2):326; author reply 326-7. doi: 10.2967/jnumed.108.054031. Epub 2009 Jan 21.
2
18Fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer: a systematic review.
J Natl Cancer Inst. 2007 Dec 5;99(23):1753-67. doi: 10.1093/jnci/djm232. Epub 2007 Nov 27.
3
The utility of fluorodeoxyglucose positron emission tomography in the evaluation of carcinoid tumors presenting as pulmonary nodules.
Chest. 2007 Jan;131(1):255-60. doi: 10.1378/chest.06-0711.
4
The maximum standardized uptake values on integrated FDG-PET/CT is useful in differentiating benign from malignant pulmonary nodules.
Ann Thorac Surg. 2006 Sep;82(3):1016-20. doi: 10.1016/j.athoracsur.2006.03.095.
5
Virtual positron emission tomography/computed tomography-bronchoscopy: possibilities, advantages and limitations of clinical application.
Eur Radiol. 2007 Mar;17(3):709-15. doi: 10.1007/s00330-006-0350-y. Epub 2006 Aug 15.
6
Molecular imaging of EGFR kinase activity in tumors with 124I-labeled small molecular tracer and positron emission tomography.
Mol Imaging Biol. 2006 Sep-Oct;8(5):262-77. doi: 10.1007/s11307-006-0049-0.
7
Positron emission tomography with C11-acetate for tumor detection and localization in patients with prostate-specific antigen relapse after radical prostatectomy.
Urology. 2006 May;67(5):996-1000. doi: 10.1016/j.urology.2005.11.044.
8
Additional value of PET-CT in the staging of lung cancer: comparison with CT alone, PET alone and visual correlation of PET and CT.
Eur Radiol. 2007 Jan;17(1):23-32. doi: 10.1007/s00330-006-0284-4. Epub 2006 May 9.
9
In vitro evaluation of adenosine 5'-monophosphate as an imaging agent of tumor metabolism.
J Nucl Med. 2006 May;47(5):837-45.
10
Evaluation of thoracic tumors with 18F-fluorothymidine and 18F-fluorodeoxyglucose-positron emission tomography.
Chest. 2006 Feb;129(2):393-401. doi: 10.1378/chest.129.2.393.
Zotero 插件